MAPT and Alzheimer disease: In this study, we investigated the effect of low-intensity FUS coupled with systemic administration of MBs on memory, pathology and proteomic changes in a triple-transgenic AD model, which displayed both progressive Aβ deposits and phosphorylated tau pathology with a similar spatial and temporal profile to that observed in human AD patients.